BSE: 532034 | NSE: | Pharmaceuticals & Drugs | Small Cap
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |||
| ROCE % ⓘ | 0.2% | 0.3% | 0.1% | 0.2% | 0.2% | 0.4% | 0.1% | -0.2% | -0.4% | 0% | - | ||
| Value Creation Index ⓘ | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0.6 | 0.6 | 1.5 | 1.3 | 1.4 | 1.4 | 1.8 | 0.3 | 0.1 | 0 | 0 | ||
| YoY Gr. Rt. % | - | 12.5% | 142.9% | -18.3% | 15.2% | -2.1% | 25.5% | -80.8% | -70.6% | -100% | - | ||
| Adj EPS ⓘ | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | -40% | -100% | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 0.9 | 0.9 | 0.9 | 8.8 | 8.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | ||
| Adj Net Profit ⓘ | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash Flow from Ops. ⓘ | 0 | 0.2 | -0.3 | 0 | 4 | 0 | -4 | 0 | 0 | 0 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 18 | -58 | -558.7 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -100% | -100% | -100% | -100% | ||||||||
| Adj EPS ⓘ | NA | -100% | NA | NA | ||||||||
| BVPS ⓘ | -0.1 | -37 | -0.4 | 0 | ||||||||
| Share Price | -17.1% | -29.8% | -8.9% | -39.1% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | ||
| Return on Equity % ⓘ | 0.2 | 0.3 | 0.2 | 0.5 | 0.3 | 0.4 | 0.1 | -0.2 | -0.4 | 0 | 0 | |
| Op. Profit Mgn % ⓘ | 5 | 7.1 | 0.6 | 5.3 | 2.8 | 1.7 | -7.4 | -10 | -46.8 | 0 | 4.3 | |
| Net Profit Mgn % ⓘ | 3.4 | 4.8 | 1 | 3.7 | 1.9 | 2.4 | 0.6 | -4.1 | -31.9 | 0 | 0 | |
| Debt to Equity ⓘ | 0 | 0.4 | 1.8 | 1.8 | 0 | 0 | 0 | 0 | 0 | 0 | - | |
| Working Cap Days ⓘ | 5,911 | 6,253 | 4,478 | 7,375 | 4,317 | 2,313 | 1,842 | 9,568 | 32,317 | 0 | 0 | |
| Cash Conv. Cycle ⓘ | 1,527 | 1,508 | 673 | 872 | 514 | 142 | -1 | 86 | 539 | 0 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0 | - |
| TTM Sales (₹ Cr.) | 0.3 | - |
| BVPS (₹.) ⓘ | 0.9 | - |
| Reserves (₹ Cr.) ⓘ | -1 | - |
| P/BV ⓘ | 1.57 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 1.26 / 1.38 |
| All Time Low / High (₹) | 0.00 / 72.85 |
| Market Cap (₹ Cr.) | 13.8 |
| Equity (₹ Cr.) | 10 |
| Face Value (₹) | 1 |
| Industry PE ⓘ | 40.9 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
